Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Escitalopram in Adult Patients With Major Depressive Disorder

ClinicalTrials.gov ID: NCT00668525

Public ClinicalTrials.gov record NCT00668525. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 1:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Fixed-dose Study of Escitalopram in Adult Patients With Major Depressive Disorder

Study identification

NCT ID
NCT00668525
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
877 participants

Conditions and interventions

Interventions

  • Escitalopram Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2008
Primary completion
Jan 31, 2009
Completion
Not listed
Last update posted
May 10, 2010

Started 2008

United States locations

U.S. sites
45
U.S. states
23
U.S. cities
42
Facility City State ZIP Site status
Forest Investigative Site Phoenix Arizona 85016
Forest Investigative Site Arcadia California 91007
Forest Investigative Site Encino California 91316
Forest Investigative Site Garden Grove California 92845
Forest Investigative Site Irvine California 92618
Forest Investigative Site Los Alamitos California 90720
Forest Investigative Site Denver Colorado 80212
Forest Investigative Site Washington D.C. District of Columbia 20016
Forest Investigative Site Bradenton Florida 34208
Forest Investigative Site Jacksonville Florida 32216
Forest Investigative Site Orlando Florida 32806
Forest Investigative Site West Palm Beach Florida 33407
Forest Investigative Site Atlanta Georgia 30328
Forest Investigative Site Newton Kansas 67114
Forest Investigative Site Overland Kansas 66221
Forest Investigative Site Baltimore Maryland 21208
Forest Investigative Site Glen Burnie Maryland 21061
Forest Investigative Site Rockville Maryland 20852
Forest Investigative Site Okemos Michigan 48864
Forest Investigative Site St Louis Missouri 63044
Forest Investigative Site Omaha Nebraska 68131
Forest Investigative Site Omaha Nebraska 68198
Forest Investigative Site Cherry Hill New Jersey 08002
Forest Investigative Site Clementon New Jersey 08021
Forest Investigative Site Brooklyn New York 11235
Forest Investigative Site New York New York 10021
Forest Investigative Site New York New York 10024
Forest Investigative Site Staten Island New York 10312
Forest Investigative Site The Bronx New York 10467
Forest Investigative Site Canton Ohio 44708
Forest Investigative Site Dayton Ohio 45408
Forest Investigative Site Portland Oregon 97210
Forest Investigative Site Media Pennsylvania 19063
Forest Investigative Site Philadelphia Pennsylvania 19107
Forest Investigative Site Charleston South Carolina 29405
Forest Investigative Site Memphis Tennessee 38117
Forest Investigative Site Memphis Tennessee 38119
Forest Investigative Site Austin Texas 78756
Forest Investigative Site Houston Texas 77008
Forest Investigative Site San Antonio Texas 78229
Forest Investigative Site Salt Lake City Utah 84107
Forest Investigative Site Woodstock Vermont 05091
Forest Investigative Site Richmond Virginia 23230
Forest Investigative Site Bellevue Washington 98004
Forest Investigative Site Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00668525, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2010 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00668525 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →